Emergent BioSolutions
EBS
#8265
Rank
โ‚น33.22 B
Marketcap
โ‚น647.95
Share price
6.13%
Change (1 day)
-5.87%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น14.78

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น16.32. In 2025 the company made an earnings per share (EPS) of โ‚น91.19 an increase over its 2024 EPS that were of -โ‚น348.45.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น14.78-116.2%
2025โ‚น91.19-126.17%
2024-โ‚น348.45-75.61%
2023-โ‚น1,429232.21%
2022-โ‚น430.05-203.46%
2021โ‚น415.65-25.09%
2020โ‚น554.84445.28%
2019โ‚น101.75-15.2%
2018โ‚น119.99-35.9%
2017โ‚น187.1969.57%
2016โ‚น110.39-27.67%
2015โ‚น152.6365.63%
2014โ‚น92.1511.63%
2013โ‚น82.5532.31%
2012โ‚น62.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.75-870.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น343.16-2,202.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น373.06-2,386.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น254.38 1,458.82%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น33.60-305.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.93 2,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น131.51-905.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel